Nancy J. Reyes, Ph.D.

Director, Clinical and Medical Affairs at Kala Pharmaceuticals

Nancy J. Reyes, Ph.D. has a diverse work experience spanning multiple roles and companies. Nancy J. is currently serving as the Director of Clinical and Medical Affairs at Kala Pharmaceuticals since July 2022. Prior to this, Nancy worked at Dompé as an Associate Scientific Director from May 2022 to July 2022. Nancy J. also held positions as a Senior Medical Science Liaison and Medical Science Liaison at Dompé from March 2021 to May 2022 and October 2019 to March 2021, respectively.

In 2019, Nancy worked at Novartis as a Senior Medical Science Liaison from July 2019 to October 2019, and at Takeda as a Senior Medical Science Liaison from January 2019 to June 2019. Before that, they worked at Shire as a Medical Science Liaison from October 2017 to January 2019.

Nancy's earlier experience includes a position as a Post-doctoral Scholar at Duke University Health System from November 2012 to October 2017. Nancy J. also served as a Ph.D. Graduate Student at UT Southwestern Medical Center at Dallas from September 2007 to August 2012. Nancy started their research career with a Summer Undergraduate Research Fellowship (SURF) at UT Southwestern Medical Center at Dallas in 2006. Prior to that, they participated in the Summer Undergraduate Research Program (SURP) at UTMB in 2005 and the Summer Undergraduate Research Program at Texas A&M University in 2004.

Throughout their career, Nancy J. Reyes, Ph.D. has gained expertise and experience in various research and medical roles, contributing to the advancement of medical science and clinical affairs.

Nancy J. Reyes, Ph.D. obtained their Bachelor of Science (B.S.) degree in Biology from St. Mary's University, where they studied from 2003 to 2007. Following their undergraduate studies, they pursued a Doctor of Philosophy (Ph.D.) in Immunology at UT Southwestern Medical Center, completing their degree from 2007 to 2012.

Links

Previous companies

Novartis logo

Org chart

Timeline

  • Director, Clinical and Medical Affairs

    July, 2022 - present

View in org chart